Carna Biosciences Inc
TSE:4572

Watchlist Manager
Carna Biosciences Inc Logo
Carna Biosciences Inc
TSE:4572
Watchlist
Price: 401 JPY 7.8% Market Closed
Market Cap: ¥7.7B

Cash Flow Statement

Cash Flow Statement
Carna Biosciences Inc

Rotate your device to view
Cash Flow Statement
Currency: JPY
Sep-2009 Mar-2010 Sep-2010 Dec-2010 Mar-2011 Jun-2011 Sep-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025 Dec-2025
Operating Cash Flow
Net Income
63
(12)
(106)
(395)
(375)
(441)
(344)
(355)
(438)
(448)
(374)
(279)
(386)
(845)
119
486
(253)
(289)
(571)
(733)
(906)
(1 207)
702
913
(904)
(1 102)
(1 487)
(532)
(101)
(1 323)
(1 843)
(1 131)
(1 353)
(2 174)
(2 138)
(2 170)
Depreciation & Amortization
47
(11)
(29)
62
56
65
42
37
37
39
35
38
56
68
26
19
20
22
19
12
12
13
9
9
11
12
16
19
24
34
37
36
34
31
16
0
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Items
(31)
1
(10)
(7)
2
(53)
(43)
(40)
(7)
(5)
(12)
(19)
(21)
207
199
(17)
(154)
(139)
52
33
61
62
61
108
104
95
71
58
84
85
51
47
62
148
125
97
Cash Taxes Paid
(1)
1
1
2
2
2
2
2
2
2
2
2
3
4
3
2
29
43
3
(12)
4
4
4
6
93
136
1
(41)
11
19
28
33
24
19
13
(14)
Cash Interest Paid
(0)
0
2
3
3
4
3
3
3
3
2
2
2
2
2
2
3
6
7
7
9
11
9
8
8
7
5
4
5
5
4
3
3
3
2
4
Change in Working Capital
(288)
117
256
30
29
82
39
7
10
(11)
11
13
48
101
(631)
(87)
602
(47)
(11)
127
(1)
4
(1 950)
448
1 989
(265)
(1)
(1 081)
6
497
(476)
(630)
295
620
(150)
(87)
Cash from Operating Activities
(209)
N/A
94
N/A
110
+17%
(310)
N/A
(288)
+7%
(347)
-21%
(307)
+12%
(351)
-14%
(398)
-14%
(425)
-7%
(340)
+20%
(247)
+27%
(304)
-23%
(469)
-54%
(269)
+43%
402
N/A
215
-47%
(453)
N/A
(512)
-13%
(561)
-10%
(834)
-49%
(1 128)
-35%
(1 178)
-4%
1 478
N/A
1 200
-19%
(1 261)
N/A
(1 401)
-11%
(1 537)
-10%
12
N/A
(708)
N/A
(2 232)
-215%
(1 677)
+25%
(961)
+43%
(1 375)
-43%
(2 147)
-56%
(2 159)
-1%
Investing Cash Flow
Capital Expenditures
6
3
(12)
(32)
(29)
(29)
(2)
(12)
(48)
(38)
(8)
(8)
(41)
(42)
(2)
(3)
(30)
(31)
(33)
(38)
(59)
(58)
(36)
(42)
(58)
(69)
(60)
(42)
(65)
(126)
(75)
(12)
(12)
(13)
(6)
(9)
Other Items
191
184
(101)
(14)
(4)
1
1
4
0
0
0
(1)
(1)
0
0
0
282
279
0
(0)
0
0
1
1
0
(2)
0
0
0
0
0
0
0
0
(16)
(16)
Cash from Investing Activities
197
N/A
187
-5%
(113)
N/A
(45)
+60%
(33)
+28%
(29)
+13%
(1)
+95%
(7)
-454%
(48)
-561%
(38)
+20%
(8)
+80%
(9)
-12%
(42)
-391%
(42)
+1%
(1)
+97%
(3)
-114%
252
N/A
248
-2%
(35)
N/A
(38)
-8%
(59)
-55%
(58)
+1%
(35)
+41%
(41)
-18%
(58)
-41%
(70)
-22%
(62)
+12%
(42)
+33%
(65)
-55%
(126)
-94%
(75)
+40%
(11)
+85%
(12)
-2%
(13)
-12%
(22)
-67%
(25)
-15%
Financing Cash Flow
Net Issuance of Common Stock
2
0
0
0
0
0
0
0
0
284
429
643
501
46
537
544
318
273
75
362
295
625
1 296
2 072
2 422
1 023
0
949
1 250
601
1 597
1 343
0
0
0
0
Net Issuance of Debt
105
98
43
109
(4)
(18)
19
17
11
(69)
(62)
6
15
20
19
53
429
481
40
(74)
219
62
(276)
42
24
(299)
(252)
110
78
(240)
(180)
(152)
(138)
(120)
(70)
613
Other
37
(50)
(70)
(70)
(20)
(20)
0
0
27
27
57
52
(5)
0
21
6
0
0
(0)
8
8
(0)
(0)
8
0
0
0
6
0
6
0
(9)
330
687
344
(8)
Cash from Financing Activities
(731)
N/A
48
N/A
(29)
N/A
39
N/A
(24)
N/A
(38)
-62%
19
N/A
17
-15%
38
+129%
241
+538%
424
+76%
701
+65%
511
-27%
67
-87%
577
+766%
603
+5%
732
+21%
755
+3%
114
-85%
296
+159%
522
+76%
688
+32%
1 019
+48%
2 122
+108%
2 453
+16%
724
-70%
(252)
N/A
1 065
N/A
1 334
+25%
367
-72%
1 423
+288%
1 182
-17%
239
-80%
567
+137%
274
-52%
605
+120%
Change in Cash
Effect of Foreign Exchange Rates
1
(2)
(2)
(1)
(2)
(2)
(0)
(0)
1
2
8
10
1
3
8
(3)
(25)
(14)
4
(2)
(2)
(2)
(1)
1
(0)
(9)
8
32
191
28
(115)
17
75
40
(71)
(12)
Net Change in Cash
(742)
N/A
328
N/A
(33)
N/A
(318)
-859%
(345)
-9%
(415)
-20%
(289)
+30%
(342)
-18%
(407)
-19%
(220)
+46%
85
N/A
456
+437%
166
-64%
(441)
N/A
314
N/A
998
+217%
1 174
+18%
536
-54%
(428)
N/A
(305)
+29%
(373)
-22%
(501)
-34%
(195)
+61%
3 560
N/A
3 596
+1%
(616)
N/A
(1 708)
-177%
(481)
+72%
1 472
N/A
(439)
N/A
(1 000)
-128%
(490)
+51%
(659)
-34%
(781)
-19%
(1 965)
-152%
(1 592)
+19%
Free Cash Flow
Free Cash Flow
(203)
N/A
97
N/A
98
+1%
(341)
N/A
(317)
+7%
(376)
-19%
(309)
+18%
(362)
-17%
(446)
-23%
(463)
-4%
(347)
+25%
(255)
+27%
(345)
-35%
(511)
-48%
(270)
+47%
399
N/A
185
-54%
(484)
N/A
(544)
-12%
(599)
-10%
(893)
-49%
(1 186)
-33%
(1 214)
-2%
1 436
N/A
1 142
-20%
(1 330)
N/A
(1 462)
-10%
(1 578)
-8%
(53)
+97%
(834)
-1 478%
(2 308)
-177%
(1 689)
+27%
(973)
+42%
(1 388)
-43%
(2 153)
-55%
(2 169)
-1%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett